Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2001
09/20/2001CA2403739A1 Three-dimensional model of a complex between a fc epsilon receptor alpha chain and a fc region of an ige antibody and uses thereof
09/20/2001CA2403397A1 Methods and compositions for rna interference
09/20/2001CA2403393A1 Methods and compositions for immunoregulation
09/20/2001CA2403373A1 A lysosomal pepstatin-insensitive proteinase as a novel biomarker for detecting and diagnosing breast cancer
09/20/2001CA2403222A1 Mitochondrial dosimeter
09/20/2001CA2402940A1 G-protein coupled receptors
09/20/2001CA2402908A1 Assay for agents that induce chemokinesis
09/20/2001CA2402873A1 Apparatus and method for high throughput electrorotation analysis
09/20/2001CA2402776A1 Mis hydrogen sensors
09/20/2001CA2402729A1 Human immune response proteins
09/20/2001CA2402530A1 Blocking leukocyte emigration and inflammation by interfering with cd99
09/20/2001CA2402483A1 Methods for detection of differences in nucleic acids
09/20/2001CA2402458A1 On-site agricultural product analysis system and method of analyzing
09/20/2001CA2402424A1 Methods of making and using microarrays of anti-ligands for the analysis of protein expression in cells
09/20/2001CA2402233A1 Methods of detecting cancer using cellular autofluorescence
09/20/2001CA2402189A1 Methods and apparatus for the location and concentration of polar analytes using an alternating electric field
09/20/2001CA2402041A1 Antisense oligonucleotides of the human chk1 gene and uses thereof
09/20/2001CA2401511A1 Fiber optic scanner
09/20/2001CA2401448A1 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/20/2001CA2401406A1 Human olfactory receptors and genes encoding same
09/20/2001CA2401273A1 Il-17 receptor like molecules and uses thereof
09/20/2001CA2401270A1 Method for labeling individual cells
09/20/2001CA2401252A1 Human and humanized fap-alpha-specific antibodies
09/20/2001CA2400978A1 Microreactor
09/20/2001CA2400825A1 Three-dimensional model of a fc region of an ige antibody and uses thereof
09/20/2001CA2400238A1 Human nim1 kinase
09/20/2001CA2399112A1 Molecular weight markers for western blot
09/20/2001CA2374155A1 A detection method of protein-protein interaction
09/20/2001CA2373414A1 A novel factor-h related protein 5 and antobodies thereto
09/19/2001EP1134687A2 Method for displaying results of hybridization experiments
09/19/2001EP1134585A2 Biosensor and method for the monitoring of herbicides
09/19/2001EP1134584A1 Induced Aggregation and Agglutination of Platelets
09/19/2001EP1134583A1 Measuring metabolic rate changes
09/19/2001EP1134576A2 Product with feature for checking the deterioration of material properties
09/19/2001EP1134574A2 Device for verifying the fuel-type contained in the tank of a motor vehicle
09/19/2001EP1134561A2 Optical volume sensor
09/19/2001EP1134290A2 Pharmacophore models for the identification of the CYP2D6 inhibitory potency of selective serotonin reuptake inhibitors
09/19/2001EP1134289A1 Method for screening cd14 agonist or antagonist
09/19/2001EP1134286A2 Adamts polypeptides, nucleic acids encoding them, and uses thereof
09/19/2001EP1133747A2 Health monitoring and diagnostic device and network-based health assessment and medical records maintenance system
09/19/2001EP1133699A1 Prevention and treatment of amyloid-associated disorders
09/19/2001EP1133698A1 Prion protein standard and method of making same
09/19/2001EP1133697A1 Method for modifying and identifying functional sites in proteins
09/19/2001EP1133696A1 Diagnosis of demyelinating or spongiform disease
09/19/2001EP1133694A1 Method and apparatus for performing a lateral flow assay
09/19/2001EP1133693A1 Test kit and method of diagnosing severe acute pancreatitis
09/19/2001EP1133692A1 Methods of identifying viral therapeutics
09/19/2001EP1133691A2 Device for organic cell culture and for studying their electrophysiological activity and membrane used in said device
09/19/2001EP1133690A1 Method for monitoring advanced separation and/or ion exchange processes
09/19/2001EP1133689A1 Method for diagnosing neoplasia
09/19/2001EP1133688A1 Method of preparing delta-9-tetrahydrocannabinol
09/19/2001EP1133686A2 Hydrogen sulfide detection tube for alcoholic beverages
09/19/2001EP1133575A2 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2
09/19/2001EP1133574A1 Methods and apparatus for flow-through hybridization
09/19/2001EP1133571A1 Methods and compositions for pain management
09/19/2001EP1133564A1 Zace1: a human metalloenzyme
09/19/2001EP1133563A2 Methods and molecules relating to cd39-like polypeptides
09/19/2001EP1133559A2 Human orphan g protein-coupled receptors
09/19/2001EP1133558A1 Compositions and methods for increasing bone mineralization
09/19/2001EP1133531A1 Water soluble fluorescent dyes free of aggregation and serum binding and related products and methods
09/19/2001EP1133523A1 Generation of antibodies using polynucleotide vaccination in avian species
09/19/2001EP1133520A2 Compositions and methods using lactadherin or variants thereof
09/19/2001EP1133516A1 Chromosome 17p-linked prostate cancer susceptibility gene
09/19/2001EP1133515A1 Dna molecules encoding hg51, a g-protein-coupled receptor
09/19/2001EP1133514A1 Method for the electrochemical detection of nucleic acid oligomer hybrids
09/19/2001EP1133513A1 Multidomain polynucleotide molecular sensors
09/19/2001EP1133352A2 Bio-assay technique
09/19/2001EP1133313A2 Calcitonin for the modulation of sperm function
09/19/2001EP1133310A2 Artery- and vein-specific proteins and uses therefor
09/19/2001EP1108212A4 Methods and materials for diagnosing unstable angina
09/19/2001EP1105517A4 Rapid quantitative analysis of proteins or protein function in complex mixtures
09/19/2001EP0968415A4 Sensor connection means
09/19/2001EP0820522B1 Assays and devices for the detection of extrahepatic biliary atresia
09/19/2001EP0649417B1 Improved chemiluminescent 1,2-dioxetanes
09/19/2001EP0634016B1 Assay verification control for analytical methods
09/19/2001EP0592624B1 Diagnostic microbiological testing apparatus and method
09/19/2001CN2449230Y Reagent kit for sperm hypotonic test
09/19/2001CN2449225Y External marked computer cell counter board
09/19/2001CN1313951A Assay to indicate the presence of non-fertilisable ova
09/19/2001CN1313950A Immunoassay testing kit and containers
09/19/2001CN1313908A Assays using crosslinkable immobilized nucleic acids
09/19/2001CN1313907A Process for preparing peptide nucleic acid probe using polymeric photoacid generator
09/19/2001CN1313906A Single nucleotide polymorphic discrimination by electronic dot blot assay on semiconductor microchips
09/19/2001CN1313891A Methods of monitoring disease states and therapies using gene expression profiles
09/19/2001CN1313864A Particles of HCV envelope proteins use of vaccination
09/19/2001CN1313771A Method for detection of i(legionella) bacteria employing purified antigen-specific antibodies
09/19/2001CN1313743A Disposable absorbent articles having translational operative members
09/19/2001CN1313726A Method for localizing allantoic fluid of avian eggs
09/19/2001CN1313511A Technique for detecting C-reactive protein by whole-blood method
09/19/2001CN1313338A Polypeptide motif bound with human CD95 and its polypeptide
09/19/2001CN1071454C Immunoassay of products and detection of chemicals by immunoassay
09/18/2001US6292756 Narrow band infrared water fraction apparatus for gas well and liquid hydrocarbon flow stream use
09/18/2001US6291693 Used in assays for the presence of vitamin d, vitamin d analogs and their metabolites which may be present in milk, blood or other biological fluids
09/18/2001US6291663 TADG-12: a novel transmembrane serine protease overexpressed in a ovarian carcinoma
09/18/2001US6291650 Methods for producing members of specific binding pairs
09/18/2001US6291649 Anti-bodies binding adhesin-derived antigens
09/18/2001US6291643 Apaf-1 an activator of caspase-3
09/18/2001US6291642 Mammalian cell cycle protein
09/18/2001US6291641 Hepatitis E virus antigens and uses therefor
09/18/2001US6291516 Contacting the cell with a composition including at least one cyclic amp agonist.